Ignite Creation Date:
2025-12-25 @ 12:03 AM
Ignite Modification Date:
2026-01-02 @ 12:33 AM
Study NCT ID:
NCT00104858
Status:
COMPLETED
Last Update Posted:
2019-07-11
First Post:
2005-03-03
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Fludarabine Phosphate, Radiation Therapy, and Rituximab in Treating Patients Who Are Undergoing Donor Stem Cell Transplant Followed by Rituximab for High-Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Sponsor:
Fred Hutchinson Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-12
Start Date Type:
ACTUAL
Primary Completion Date:
2018-03-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-03-30
Completion Date Type:
ACTUAL
First Submit Date:
2005-03-03
First Submit QC Date:
None
Study First Post Date:
2005-03-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-03-27
Results First Submit QC Date:
None
Results First Post Date:
2019-07-11
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-06-20
Last Update Post Date:
2019-07-11
Last Update Post Date Type:
ACTUAL